Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Inside Genomics Pioneer Craig Venter’s Latest Production

    Jul 25, 2016, 16:49 PM by Michael Croft
    MIT Technology Review | His startup is using data to unlock the connections between DNA and illness.
    Full story
  • BC Platforms to Partner with Codigo46 to support the creation of the largest biobank in Latin-America

    Jul 25, 2016, 03:14 AM by Michael Croft
    BASEL, SWITZERLAND - Jul 25, 2016 -  BC Platforms, a world leader in genomic data management solutions today announces that it has signed a partnership with Codigo46, an emerging Mexican company, focused on building and managing the largest biobank in Latin-America in co-operation with Mexican health and research specialists to deliver clinical patient benefits and future personalised medicines through academic and commercial research
    Full story
  • Chinese scientists to pioneer first human CRISPR trial

    Jul 22, 2016, 10:38 AM by Michael Croft
    Nature News & Comment | Gene-editing technique to treat lung cancer is due to be tested in people in August. Sichuan University's West China Hospital in Chengdu plans to inject lung cancer patients with cells modified using the CRISPR-Cas9 gene-editing technique. The clinical trial received ethical approval from the hospital July 6.
    Full story
  • Certara Appoints Nathan Teuscher to Lead Phoenix Software Division

    Jul 21, 2016, 12:37 PM by Michael Croft
    PRINCETON, NJ - Jul 21, 2016 - Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced the appointment of Nathan Teuscher, PhD, to vice president of pharmacometric solutions
    Full story
  • Bioz Launches Life Sciences Search Engine

    Jul 20, 2016, 14:35 PM by Michael Croft
    Bio-IT World | Bioz, Inc. came out of stealth today with the introduction of a search engine for life science experimentation. The company, started by Stanford research scientist Karin Lachmi and serial entrepreneur Daniel Levitt, also announced $3 million in seed funding, led by 5AM Ventures.
    Full story
  • Mitsubishi Tanabe Joins Certara’s Simcyp Consortium

    Jul 20, 2016, 08:07 AM by Michael Croft
    PRINCETON, NJ - Jul 20, 2016 - Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced that Mitsubishi Tanabe has joined its Simcyp Consortium and licensed its proprietary Simcyp® Population-based Simulator
    Full story
  • The Seven Bridges CGC: Boon for Bioinformatics, Success for a Startup

    Jul 20, 2016, 04:55 AM by Michael Croft
    Bio-IT World It's been a busy two years for Seven Bridges. In May 2014, Seven Bridges was introducing its open source cancer informatics pipeline: open source algorithms running on the proprietary Seven Bridges cloud infrastructure. Less than six months later, the company was awarded one of three National Cancer Institute Cloud Pilot contracts.
    Full story
  • Indivumed and Definiens Partner to Unlock the Power of Tumor Tissue for Drug Discovery and Development

    Jul 19, 2016, 10:02 AM by Michael Croft
    MUNICH, GERMANY - Jul 19, 2016 - Definiens, the pioneer in Tissue Phenomics solutions for diagnostics development and commercialization and Indivumed, GmbH, based in Hamburg, Germany announced today a strategic partnership to offer a unique combination of tissue-based biomarker validation and assay development with Definiens Cognition Network Technology® for image analysis and data mining
    Full story
  • NewLeaf Symbiotics Appoints VP for Research and Discovery

    Jul 19, 2016, 09:20 AM by Michael Croft
    ST. LOUIS, MO, UNITED STATES - Jul 19, 2016 - NewLeaf Symbiotics, announced today the appointment of Dr. Janne Kerovuo as Vice President for Research and Discovery
    Full story
  • Systems Toxicology Computational Challenge Results Announced

    Jul 18, 2016, 13:45 PM by Michael Croft
    Bio-IT World | The Systems Toxicology Computational Challenge results have been announced from the fourth challenge launched by sbv IMPROVER, an international scientific crowdsourcing initiative.
    Full story
  • Appistry’s Vision for Clinical Lab Analysis

    Jul 15, 2016, 05:50 AM by Michael Croft
    Bio-IT World | Appistry launches managed services for clinical sequencing, incorporating GenomePilot, and covering the entire pipeline from when data comes off the sequencers to results analysis.
    Full story
  • With new owner the hated impact factor is overdue for change

    Jul 14, 2016, 09:47 AM by Michael Croft
    STAT | The impact factor is a poor measure of a journal's quality, and academics say it should either be overhauled or done away with entirely.
    Full story
  • Wellcome Trust launches open-access publishing venture

    Jul 13, 2016, 08:16 AM by Michael Croft
    Nature News & Comment | Wellcome Open Research is meant to allow Wellcome grant recipients to publish their findings more quickly. The charity hopes other funders will follow a similar model. Management of the venture will be contracted to F1000Research.
    Full story
  • Genomic Medicine Training, New Storage Options, Food Allergy Science

    Jul 12, 2016, 15:10 PM by Michael Croft
    Bio-IT World | News and product launches from around the Bio-IT landscape include a postdoctoral fellowship in genomics medicine in Alabama, a synthetic biology partnership, new Lustre storage, and the Broad's food allergy science institute.
    Full story
  • A Drug For Postpartum Depression? Sage Passes Early Test With Experimental Treatment

    Jul 12, 2016, 14:48 PM by Michael Croft
    Forbes | Encouraging news is out today for the treatment of severe postpartum depression. Sage Therapeutics, a biotech company in Cambridge, Mass., reported that its experimental drug was able to relieve severe symptoms of postpartum depression for 70% of patients within a few days, and keep them in remission for a month.
    Full story
  • Danforth Plant Science Center and Valent BioSciences will Collaborate in Unique Root Science Initiative

    Jul 12, 2016, 13:07 PM by Michael Croft
    ST. LOUIS, MO, UNITED STATES - Jul 12, 2016 - Valent BioSciences Corporation (VBC) and the Donald Danforth Plant Science Center today announced the finalization of a multi-year, Master Cooperation Agreement in the area of root science and the rhizosphere
    Full story
  • Crop Roots Enact Austerity Measures During Drought to Bank Water

    Jul 11, 2016, 17:29 PM by Michael Croft
    ST. LOUIS, UNITED STATES - Jul 11, 2016 - With a growing world population and a changing climate, understanding how agriculturally important plants respond to drought is crucial
    Full story
  • Intel's Cancer Cloud: Complementing NCI Collaboration

    Jul 11, 2016, 13:25 PM by Michael Croft
    Bio-IT World | Intel may have missed out on a major government grant, but that hasn't stopped it from developing a collaborative cloud for genomicists and bioinformaticians that it wanted to build all along.
    Full story
  • IT spending will shrink worldwide due to Brexit Gartner predicts

    Jul 8, 2016, 08:47 AM by Michael Croft
    Computerworld | Britain's vote to exit the European Union will depress global IT spending, according to Gartner analyst John-David Lovelock.
    Full story
  • Juno Therapeutics Stops Trial Of Cancer-Killing Cells After 3 Patient Deaths

    Jul 8, 2016, 08:38 AM by Michael Croft
    Forbes | Three patients have died in a closely watched study of using genetically engineered white blood cells to treat adult leukemia patients, forcing the trial to be put on hold. The news is a blow for Juno Therapeutics, the biotechnology startup valued at $4.3 billion.
    Full story
  • «
  • 341 (current)
  • 342
  • 343
  • 344
  • 345
  • 346
  • 347
  • 348
  • 349
  • 350
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy